PAQ Therapeutics

PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring health and curing disease through autophagy, the body’s most versatile mechanism for natural cellular degradation.

PAQ uses its ATTEC (autophagosome-tethering compound) technology, where small molecules can selectively enhance the degradation of disease causing entities. PAQ’s research advances are driving an important new class of degradation therapies with the potential to target a range of substrates including proteins, aggregates, lipids, organelles and pathogens.

The company’s initial focus is on a genetic neurodegenerative disorder with no current treatment options for patients. PAQ plans to expand the ATTEC platform to target additional disease-causing protein and non-protein targets.

PAQ was founded in 2020 by Boxun Lu, Huaixiang Hao, and Nan Ji, and raised US $30 million is a Series A round in July 2021.

Subscribe for alerts on new companies featured on Startups.Bio

Therorna
Therorna was founded in China in 2021, leveraging its proprietary circular RNA technology platform to develop next-generation vaccines and innovative therapies. Compared with linear RNA, circular RNA (circRNA) offers benefits …
Tamarix Pharma
Tamarix Pharma was founded in 2021 based on technology licensed from the National Institute for Biotechnology in the Negev (Israel) and is focused on developing novel technologies that restore physiological …
BacVax
BacVax is a spin-off from the University of Arizona with a novel approach to developing vaccines against bacterial infections by mapping the proteins on the surface of bacteria. BacVax's approach …
Lento Bio
Lento Bio was founded in 2022 in collaboration with Ichor Life Sciences and Clarkson University’s Shipley Center for Innovation, with the goal to develop effective, safe, and durable treatments for …

View all recently featured startups

Tags:

Get 15% off a VentureRadar Subscription

Pay through the following Startups.Bio discount page when you upgrade.
Use it now or save it for later.

Active during June and July 2022 only

View
X